Meatable Funding: $95M Raised, Series B (2023)

Meatable is a Biotech company. It has raised $95M in total funding. Latest round: Series B. Backed by Agronomics, Invest-NL, BlueYard.

Meatable funding overview

Meatable is a Biotech company. Meatable has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2023. The round record for Meatable runs through 2023; nothing later has been disclosed. Investors on record include Agronomics, Invest-NL, BlueYard, Bridford Group, Milky Way Ventures, DSM Venturing and 1 others. 7 distinct backers are named across the disclosed rounds.

Meatable at a glance

Total raised
$95M
Latest round
Series B
Latest round date
August 2023
Industry
Biotech
Notable investors
Agronomics, Invest-NL, BlueYard, Bridford Group, Milky Way Ventures, DSM Venturing, Taavet Hinrikus

Frequently asked about Meatable funding

How much has Meatable raised?
Meatable has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Meatable?
Agronomics, Invest-NL, BlueYard, Bridford Group, Milky Way Ventures, DSM Venturing are named among the investors backing Meatable.
What was the latest Meatable funding round?
The most recent disclosed round is a Series B, announced in August 2023.
Where is Meatable based?
No headquarters location is disclosed for Meatable.
What sector does Meatable operate in?
Meatable is tracked under Biotech, with $95M in disclosed funding.
When did Meatable last raise?
The last disclosed Meatable round closed in August 2023 at Series B.

We update the Meatable record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.

Companies related to Meatable (26)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026